APRIL 2023 Research Alert

This month we added three new studies to the Best Practice Database, the research repository for Best Practices, LLC. This month's new studies explore two topical areas: launching in a captive market and constructing Medical’s road map for social media success in Immunology. The first case study is about how argenx broke into the captive gMG market with its first product, VYVGART. The last two studies investigate current trends and success factors in harnessing social media for effectively educating the Immunology market.

The new Best Practices, LLC studies listed below under Newly Added Research explore how leading companies have made their operations more effective across these different areas.

	Download: Case Study: How argenx Broke Into A Captive Market To Begin Dislodging An Entrenched Market Leader (5757) This case study reviews VYVGART’s trajectory to breaking into the captive gMG market to begin dislodging an entrenched market leader. The study probes the development, launch, and market entry strategies executed by argenx to launch VYVGART as a first step in its rare disease franchise building.
	Download: Medical’s Road Map for Social Media Success in Immunology: Structure and Activities (5758) This benchmark study examines the optimal structure for Medical Affairs groups to engage in social media initiatives and highlights key social media activities for effectively educating the Immunology market. Medical Affairs leaders can refer to this research to unlock the power of social media.
	Download: Medical’s Road Map for Social Media Success in Immunology: Omnichannel Integration and Message Characteristics (5759) Best Practices, LLC undertook this research to establish benchmarks around social media omnichannel integration, social media message characteristics, and performance measurement.